Rojan İpek

Dr. Rojan İpek

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SBSema Bozkaya-Yilmaz
Sema Bozkaya-Yilmaz
EKEda Karadag-Oncel
Eda Karadag-Oncel
NDNihal Olgac Dundar
Nihal Olgac Dundar
PGPINAR GENCPINAR
PINAR GENCPINAR
BSBerrak Sarioglu
Berrak Sarioglu
DÇDilek Çavuşoğlu
Dilek Çavuşoğlu

29 October 2022 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
RİRojan İpek
Rojan İpek
BÇBüşra Eser Çavdartepe
Büşra Eser Çavdartepe
DKDeniz Kor
Deniz Kor
ÇOÇetin Okuyaz
Çetin Okuyaz

3 January 2024 in Pediatric Neurology
Verified
Journal Article
Closed access
BDBeril Dilber
Beril Dilber
ESEsra Serdaroğlu
Esra Serdaroğlu
SKSeda Kanmaz
Seda Kanmaz
BKBetül Kılıç
Betül Kılıç
RİRojan İpek
Rojan İpek
ACAli Cansu
Ali Cansu

27 February 2025 in neurogenetics
Verified
Journal Article
Closed access
PDF file
RİRojan İpek
Rojan İpek
AAAkçahan Akalın
Akçahan Akalın
EHEsra Habiloğlu
Esra Habiloğlu
SHSalih Hattapoğlu
Salih Hattapoğlu
APAyfer Gözü Pirinççioğlu
Ayfer Gözü Pirinççioğlu

11 January 2023 in Molecular Syndromology
Verified
Journal Article
Open access
PDF file
BÇBüşra Eser Çavdartepe
Büşra Eser Çavdartepe
RİRojan İpek
Rojan İpek
Introduction: Osteogenesis imperfecta (OI) is a heritable disorder characterized by bone fractures and low bone mass. Recently, mutations of the WNT1 gene have been reported to be causative in OI. The mutation in WNT1 causes autosomal-recessive OI due to its critical role in bone formation. WNT1 mutations cause varying degrees of clinical severity, ranging from moderate to progressively deforming forms. In addition to the OI phenotype, our cases also had extra-skeletal findings. Case Presentation: We describe two siblings with multiple fractures and developmental delay. A novel homozygous frameshift WNT1 mutation was detected in this family, and we reviewed the literature for WNT1-related OI cases. Discussion: We report a novel variant with a clinical diagnosis of severe OI, and this review will provide a comprehensive overview of previously published cases of OI type XV. With a better understanding of disorders associated with WNT1 mutations, therapies targeting Wnt1 signaling pathway may contribute therapeutic benefits.

Verified
Journal Article
Open access
PDF file
SBSavas Baris
Savas Baris
RİRojan İpek
Rojan İpek
SBSaniye Tugba Baris
Saniye Tugba Baris
IBIbrahim Baris
Ibrahim Baris
Biallelic variants in NDUFS6, encoding an accessory subunit of mitochondrial complex I, were initially associated with lethal neonatal mitochondrial encephalopathy and Leigh syndrome. Recent studies have demonstrated that NDUFS6 variants can also cause childhood- or adolescent-onset axonal neuropathy and Charcot–Marie–Tooth (CMT)-like phenotypes, indicating marked clinical heterogeneity. Here, we report a patient with a novel homozygous truncating NDUFS6 variant presenting with a neuropathy-predominant phenotype accompanied by epilepsy, in the absence of neonatal metabolic decompensation. The patient presented with childhood-onset progressive gait abnormality, pes cavus deformity, distal weakness requiring Achilles tendon-release surgery, pyramidal signs, urinary incontinence, and focal epileptiform EEG findings. Brain MRI showed bilateral lenticular nucleus abnormalities. Whole-exome sequencing identified a novel homozygous NDUFS6 nonsense variant (c.130C>T, p.Gln44*). While neuropathy has previously been reported primarily in association with the recurrent splice-site variant c.309+5G>A, our findings demonstrate that truncating NDUFS6 mutations can also underlie a neuropathy-predominant phenotype. Together with previously published cases, our findings support a phenotypic heterogeneity ranging from lethal encephalopathy to neuropathy and reinforce the role of NDUFS6 as a disease-causing gene for inherited peripheral neuropathy. These data support inclusion of NDUFS6 among established neuropathy and Charcot–Marie–Tooth genes.